Who
Martin J. Gepsman
Director
Company insider
Files Form 4 as: Director, CME Group.
In numbers
- Trades disclosed
- 67
- Buys
- 0
- Sells
- 34
- Bought
- $0
- Sold
- $5.2M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 25 May 2006
- Last trade
- 22 Oct 2026
- Last filed
- 22 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Oct 2026filed 22 Oct 2026 | CME CME GroupExchanges & fin. data | SEC FORM 4 Sold | $121K400 at $302.50 | filing |
| 25 Jun 2026filed 29 Jun 2026 | CME CME GroupExchanges & fin. data | SEC FORM 4 Code A | $145K645 at $225.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | CME CME GroupExchanges & fin. data | SEC FORM 4 Code A | $145K645 at $225.00 | filing |
| 20 Feb 2026filed 20 Feb 2026 | CME CME GroupExchanges & fin. data | SEC FORM 4 Sold | $92K300 at $305.90 | filing |
| 20 Feb 2026filed 20 Feb 2026 | CME CME GroupExchanges & fin. data | SEC FORM 4 Sold | $92K300 at $305.90 | filing |
| 25 Jun 2025filed 26 Jun 2025 | CME CME GroupExchanges & fin. data | SEC FORM 4 Code A | $145K532 at $273.03 | filing |
| 15 May 2025filed 19 May 2025 | CME CME GroupExchanges & fin. data | SEC FORM 4 Sold | $82K300 at $273.17 | filing |
| 4 Nov 2024filed 4 Nov 2024 | CME CME GroupExchanges & fin. data | SEC FORM 4 Sold | $89K400 at $222.92 | filing |
| 25 Jun 2024filed 26 Jun 2024 | CME CME GroupExchanges & fin. data | SEC FORM 4 Code A | $145K748 at $194.10 | filing |
| 26 Oct 2023filed 26 Oct 2023 | CME CME GroupExchanges & fin. data | SEC FORM 4 Sold | $65K300 at $216.33 | filing |
| 26 Jun 2023filed 28 Jun 2023 | CME CME GroupExchanges & fin. data | SEC FORM 4 Code A | $145K811 at $178.89 | filing |
| 27 Jun 2022filed 29 Jun 2022 | CME CME GroupExchanges & fin. data | SEC FORM 4 Code A | $145K693 at $209.44 | filing |
| 25 Jan 2022filed 26 Jan 2022 | CME CME GroupExchanges & fin. data | SEC FORM 4 Code A | $10K47 at $221.79 | filing |
| 7 Dec 2021filed 9 Dec 2021 | CME CME GroupExchanges & fin. data | SEC FORM 4 Sold | $116K500 at $231.00 | filing |
| 28 Oct 2021filed 28 Oct 2021 | CME CME GroupExchanges & fin. data | SEC FORM 4 Sold | $32K147 at $218.24 | filing |
| 28 Oct 2021filed 28 Oct 2021 | CME CME GroupExchanges & fin. data | SEC FORM 4 Sold | $23K104 at $218.29 | filing |
| 28 Oct 2021filed 28 Oct 2021 | CME CME GroupExchanges & fin. data | SEC FORM 4 Sold | $54K249 at $218.27 | filing |
| 13 Sep 2021filed 13 Sep 2021 | CME CME GroupExchanges & fin. data | SEC FORM 4 Sold | $189K1,000 at $188.54 | filing |
| 7 Sep 2021filed 8 Sep 2021 | CME CME GroupExchanges & fin. data | SEC FORM 4 Sold | $194K1,000 at $194.25 | filing |
| 30 Aug 2021filed 30 Aug 2021 | CME CME GroupExchanges & fin. data | SEC FORM 4 Sold | $20K100 at $201.03 | filing |
News
CME (NASDAQ: CME) tops record Q3 revenue as ADV and market data riseCME · themarketsdaily.com · 21 Oct 2026Analyzing Stifel Financial (NYSE:SF) and CME Group (NASDAQ:CME)CME · dailypolitical.com · 21 Oct 2026
0 headlines in the last 90 days name Martin J. Gepsman; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.